skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
Sonepcizumab (Code C78195)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Sonepcizumab

Definition: A humanized monoclonal antibody directed against sphingosine 1-phosphate (S1P) with potential antiangiogenic and antineoplastic activities. Upon administration, sonepcizumab binds S1P, which may result in the inhibition of tumor angiogenesis. S1P is the extracellular ligand for the G protein-coupled lysophospholipid receptor EDG-1 (endothelial differentiation gene-1).

Label: Sonepcizumab

NCI Thesaurus Code: C78195 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: CL383585  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Asonep
LT1009
Sonepcizumab

External Source Codes: 
PDQ Closed Trial Search ID 595163
PDQ Open Trial Search ID 595163 (check for NCI PDQ open clinical trial info)
NCI META CUI CL383585

Other Properties:
     Name Value (qualifiers indented underneath)
code C78195
Legacy_Concept_Name Sonepcizumab
Semantic_Type Amino Acid, Peptide, or Protein
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  

URL: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C78195

Mainbox Bottom